Temperature-dependent insertion of genetic material into genomic DNA

• US 20140193859A1
• Filed: 01/07/2014
• Published: 07/10/2014
• Est. Priority Date: 01/08/2013
• Status: Abandoned Application

• Current Assignee: Arizona Board of Regents (University of Arizona)
• Original Assignee: Bertram Jacobs, Karen Kibler
• Inventors: JACOBS, Bertram, KIBLER, Karen
• Application Number:
  US14/149,398
• Publication Number:
  US 20140193859A1
• Time in Patent Office: Days
• US Class Current: 435/91.41
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C12N 15/66 General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
• CPC Class Codes: C12N 15/86 Viral vectors
• CPC Class Codes: C12N 2710/24143 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2800/40 Systems of functionally co-operating vectors
• CPC Class Codes: C12N 2800/50 Vectors for producing vectors
• CPC Class Codes: C12N 2830/002 inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Abstract

The present invention provides improved methods and reagents for insertion of genetic material into genomic DNA.

Claims

1. A method for insertion of genetic material into genomic DNA comprising

(a) incubating host cells comprising recipient viral vector and donor nucleic acid vector under conditions and for a time suitable for promoting recombination between the recipient viral vector and the donor nucleic acid vector, wherein

(i) the recipient viral vector comprises

(A) a gene encoding a toxic protein, wherein expression of the toxic protein is temperature sensitive;

or the toxic protein itself is only toxic at a particular temperature; and

(B) two recombination sites flanking the gene encoding the toxic protein, wherein the two recombination sites are unique in the recipient viral vector;

wherein

(ii) the donor nucleic acid vector comprises

(A) a donor gene; and

(B) two recombination sites flanking the donor gene, wherein the two recombination sites are (I) unique in the donor nucleic acid vector, and (II) identical to the two recombination sites in the recipient viral vector; and

wherein

(iii) the host cell comprises a promiscuous DNA polymerase capable of synthesizing recipient viral vector DNA, and

wherein the conditions comprise incubating the host cells at a first temperature at which the toxic protein is not expressed;

(b) subsequently culturing the host cells at a second temperature at which the toxic protein is expressed by the recipient viral vector; and

(c) selecting viruses that grow at the second temperature, wherein viruses that grow at the second temperature are recombinant recipient viral vectors in which the donor gene has been inserted into the recipient viral vector, replacing the toxic gene.

2. The method of claim 1, wherein the host cell is a eukaryotic cell.

3. The method of claim 1, wherein the host cell is a mammalian cell.

4. The method of claim 1, wherein the recipient viral vector comprises a Pox viral genome.

5. The method of claim 1, wherein the recipient viral vector comprises a vaccinia viral genome.

6. The method of claim 1, wherein the toxic protein is selected from the group consisting of protein kinase R (PKR), DNAses, RNAses, restriction endonucleases, proteases, and proteins that induce apoptosis.

7. The method of claim 1, wherein expression of the gene encoding the toxic protein is controlled by a heterologous temperature sensitive regulatory system, wherein the temperature sensitive element is present, or is encoded by a nucleic acid present, between the two recombination sites.

8. The method of claim 7, wherein the heterologous temperature sensitive regulatory system comprises a system selected from the group consisting of (i) temperature sensitive lac repressor, wherein the gene encoding the toxic protein is operatively linked to a Lac operator, (ii) temperature-sensitive λ

repressor CI857, and (iii) lactic acid bacteriophage temperature-inducible gene expression systems.

9. The method of claim 1 wherein the donor nucleic acid vector comprises a donor gene encoding a therapeutic protein and/or an antigen for vaccine production.

10. The method of claim 1, wherein the DNA polymerase is a Pox virus DNA polymerase.

11. The method of claim 1, wherein the DNA polymerase is a vaccinia virus DNA polymerase.

12. A nucleic acid cassette, comprising:

(a) a gene encoding a toxic protein;

(b) a regulatory element operatively linked to the gene encoding the toxic protein; and

(c) a temperature sensitive repressor of the regulatory element.

13. The cassette of claim 12, wherein the toxic protein is selected from the group consisting of protein kinase R (PKR), DNAses, RNAses, restriction endonucleases, proteases, and proteins that induce apoptosis.

14. The cassette of claim 12, wherein the regulatory element comprises a lac operator and the temperature sensitive repressor comprises a temperature sensitive lac repressor

15. A recombinant viral vector, comprising

(a) a gene encoding a toxic protein, wherein expression of the toxic protein is temperature sensitive;

and

(b) two recombination sites flanking the gene encoding the toxic protein, wherein the two recombination sites are unique in the recipient viral vector.

16. The recombinant viral vector of claim 15, further comprising:

(c) a regulatory element operatively linked to the gene encoding the toxic protein; and

(d) a temperature sensitive repressor of the temperature sensitive regulatory system.

17. The recombinant viral vector of claim 15, wherein the toxic protein is selected from the group consisting of protein kinase R (PKR), DNAses, RNAses, restriction endonucleases, proteases, and proteins that induce apoptosis.

18. The recombinant viral vector of claim 16, wherein the regulatory element comprises a lac operator and the temperature sensitive repressor comprises a temperature sensitive lac repressor

19. Recombinant viral particles comprising the recombinant viral vectors of claim 15.